Jianfa Li

1.8k total citations
35 papers, 1.4k citations indexed

About

Jianfa Li is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Jianfa Li has authored 35 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 25 papers in Cancer Research and 4 papers in Genetics. Recurrent topics in Jianfa Li's work include Cancer-related molecular mechanisms research (23 papers), RNA modifications and cancer (15 papers) and Circular RNAs in diseases (9 papers). Jianfa Li is often cited by papers focused on Cancer-related molecular mechanisms research (23 papers), RNA modifications and cancer (15 papers) and Circular RNAs in diseases (9 papers). Jianfa Li collaborates with scholars based in China, Hong Kong and Israel. Jianfa Li's co-authors include Yuchen Liu, Weiren Huang, Chengle Zhuang, Zhicong Chen, Zhiming Cai, Anbang He, Mingwei Chen, Yonghao Zhan, Junhao Lin and Yaoting Gui and has published in prestigious journals such as Nature Methods, Scientific Reports and The FASEB Journal.

In The Last Decade

Jianfa Li

35 papers receiving 1.3k citations

Peers

Jianfa Li

SURGE

ONCOL

PRM

Jingwen Hu China

Guozhong Ji China

Dessislava A. Nikolova Germany

Meimei Wan United States

Xuchao Xue China

Duo Wen China

Bruno Pereira Portugal

Zerong Cai China

Yong Sun China

Jingwen Hu China

Jianfa Li

1.1k ×0.9

1.0k ×1.0

51 ×0.5

SURGE

69 ×0.8

ONCOL

67 ×0.8

PRM

Citations per year, relative to Jianfa Li Jianfa Li (= 1×) peers Jingwen Hu

Countries citing papers authored by Jianfa Li

Since Specialization

Citations

This map shows the geographic impact of Jianfa Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianfa Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianfa Li more than expected).

Fields of papers citing papers by Jianfa Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianfa Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianfa Li. The network helps show where Jianfa Li may publish in the future.

Co-authorship network of co-authors of Jianfa Li

This figure shows the co-authorship network connecting the top 25 collaborators of Jianfa Li. A scholar is included among the top collaborators of Jianfa Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianfa Li. Jianfa Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Wenjin, Chenchen Huang, Hui Shan, et al.. (2024). Higher concentration of P7C3 than required for neuroprotection suppresses renal cell carcinoma growth and metastasis. Journal of Cancer. 15(5). 1191–1202. 1 indexed citations

Tan, Mingyue, Qi Pan, Qi Wu, Jianfa Li, & Jun Wang. (2023). Aldolase B attenuates clear cell renal cell carcinoma progression by inhibiting CtBP2. Frontiers of Medicine. 17(3). 503–517. 4 indexed citations

Li, Mengqing, et al.. (2021). Angiotensin II promotes EMT of hepatocellular carcinoma cells through high mobility group protein B1 mediated by E4F1. Biochemical and Biophysical Research Communications. 547. 198–203. 6 indexed citations

Huang, Chenchen, Jianfa Li, Fangfang Chen, et al.. (2020). LncRNA NRON promotes the proliferation, metastasis and EMT process in bladder cancer. Journal of Cancer. 11(7). 1751–1760. 17 indexed citations

Zhan, Hengji, Qun Zhou, Qunjun Gao, et al.. (2019). Multiplexed promoterless gene expression with CRISPReader. Genome biology. 20(1). 113–113. 20 indexed citations

Li, Jianfa, et al.. (2019). PCAT-1: A Novel Oncogenic Long Non-Coding RNA in Human Cancers. International Journal of Biological Sciences. 15(4). 847–856. 44 indexed citations

Li, Jianfa, Chenchen Huang, Changshui Zhuang, et al.. (2019). A CRISPR Interference of CBP and p300 Selectively Induced Synthetic Lethality in Bladder Cancer Cells In Vitro. International Journal of Biological Sciences. 15(6). 1276–1286. 28 indexed citations

Ding, Mengting, Yuhan Liu, Jianfa Li, et al.. (2018). Oestrogen promotes tumorigenesis of bladder cancer by inducing the enhancer RNA—eGREB1. Journal of Cellular and Molecular Medicine. 22(12). 5919–5927. 13 indexed citations

Xie, Haibiao, Bo Ma, Qunjun Gao, et al.. (2018). Long non-coding RNA CRNDE in cancer prognosis: Review and meta-analysis. Clinica Chimica Acta. 485. 262–271. 40 indexed citations

10.

Li, Jianfa, et al.. (2018). The Function and Mechanism of Long Non-coding RNA-ATB in Cancers. Frontiers in Physiology. 9. 321–321. 46 indexed citations

11.

Xie, Haibiao, Hengji Zhan, Qunjun Gao, et al.. (2018). Synthetic artificial "long non-coding RNAs" targeting oncogenic microRNAs and transcriptional factors inhibit malignant phenotypes of bladder cancer cells. Cancer Letters. 422. 94–106. 9 indexed citations

12.

Gao, Qunjun, Haibiao Xie, Hengji Zhan, et al.. (2017). Prognostic Values of Long Noncoding RNA GAS5 in Various Carcinomas: An Updated Systematic Review and Meta-Analysis. Frontiers in Physiology. 8. 814–814. 22 indexed citations

13.

Xie, Haibiao, et al.. (2017). Colon cancer associated transcripts in human cancers. Biomedicine & Pharmacotherapy. 94. 531–540. 32 indexed citations

14.

Xie, Haibiao, Xinhui Liao, Zhicong Chen, et al.. (2017). LncRNA MALAT1 Inhibits Apoptosis and Promotes Invasion by Antagonizing miR-125b in Bladder Cancer Cells. Journal of Cancer. 8(18). 3803–3811. 83 indexed citations

15.

Li, Jianfa, et al.. (2017). BANCR: a novel oncogenic long non-coding RNA in human cancers. Oncotarget. 8(55). 94997–95004. 23 indexed citations

16.

Liu, Yuchen, Yonghao Zhan, Zhicong Chen, et al.. (2016). Directing cellular information flow via CRISPR signal conductors. Nature Methods. 13(11). 938–944. 148 indexed citations

17.

He, Anbang, Yuchen Liu, Zhicong Chen, et al.. (2016). Over-expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer. Journal of Experimental & Clinical Cancer Research. 35(1). 125–125. 53 indexed citations

18.

Chen, Mingwei, Chengle Zhuang, Yuchen Liu, et al.. (2016). Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer. Cancer Letters. 376(1). 155–164. 80 indexed citations

19.

Li, Jianfa, Chengle Zhuang, Yuchen Liu, et al.. (2016). Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer. Journal of Experimental & Clinical Cancer Research. 35(1). 99–99. 61 indexed citations

20.

Liu, Yuchen, Zhicong Chen, Anbang He, et al.. (2016). Targeting cellular mRNAs translation by CRISPR-Cas9. Scientific Reports. 6(1). 29652–29652. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact